-+ 0.00%
-+ 0.00%
-+ 0.00%

Harvard Bioscience Sees Q4 Sales $23.700M-$25.500M vs $24.500M Est

Benzinga·11/10/2026 12:04:00
Listen to the news
Harvard Bioscience (NASDAQ:HBIO) sees Q4 sales of $23.700 million-$25.500 million vs $24.500 million analyst estimate.